Urovision Diagnostics & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 8.17 M
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.75 Cr
About Urovision Diagnostics & Research Centre
Urovision Diagnostics & Research Centre Private Limited (UDRCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 March 2001 and has a history of 23 years and ten months. Its registered office is in Dibrugarh, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 8.17 M.
The company currently has active open charges totaling ₹3.75 Cr.
Aparajit Sandilya, Prakritee Sandilya, and Mitali Borooah serve as directors at the Company.
Company Details
- Location
Dibrugarh, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110AS2001PTC006473
- Company No.
006473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Urovision Diagnostics & Research Centre?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aparajit Sandilya  | Director | 02-Apr-2012 | Current |
| Prakritee Sandilya | Director | 05-Sep-2016 | Current |
| Mitali Borooah | Director | 06-Sep-2023 | Current |
Financial Performance of Urovision Diagnostics & Research Centre.
Urovision Diagnostics & Research Centre Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Urovision Diagnostics & Research Centre?
In 2023, Urovision Diagnostics & Research Centre had a public holding of 1.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 2.70 Cr
- Hdfc Bank Limited : 0.99 Cr
- State Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2024 | State Bank Of India | ₹0.61 M | Open |
| 27 Jan 2023 | Indian Overseas Bank | ₹2.00 M | Open |
| 20 Aug 2021 | Indian Overseas Bank | ₹3.20 M | Open |
| 26 Mar 2021 | Hdfc Bank Limited | ₹9.90 M | Open |
| 20 Feb 2015 | Indian Overseas Bank | ₹1.85 Cr | Open |
How Many Employees Work at Urovision Diagnostics & Research Centre?
Urovision Diagnostics & Research Centre has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urovision Diagnostics & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urovision Diagnostics & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
